Mangoceuticals, Inc. Public Float
Mangoceuticals, Inc. (MGRX) had Public Float of $14.73 million as of 2025-06-30, per its 10-K filed 2026-04-01.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-01
- 2025-06-30: Entity Public Float $14.73M.
- 2024-06-30: Entity Public Float $5.86M.
- 2023-06-30: Entity Public Float $13.43M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $14.73M 10-K · filed 2026-04-01 |
| 2024-06-30 | $5.86M 10-K · filed 2025-03-20 |
| 2023-06-30 | $13.43M 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |